Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ichikawa

Showing results (441-450 of 466) with videos related to

Pageof 47
Sort By:
Leukemia|October 7, 2015
A20 targets caspase-8 and FADD to protect HTLV-I-infected cellsY Saitoh, A Hamano, K Mochida, et al.
Artificial Organs|July 1, 1997
Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypassK Kagisaki, T Masai, K Kadoba, et al.
Oncogene|September 6, 2006
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinomaD G Jackson-Bernitsas, H Ichikawa, Y Takada, et al.
Genomics|April 1, 1996
A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21M Ohira, H Ichikawa, E Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Long-distance restriction mapping of the proximal long arm of human chromosome 21 with Not I linking clonesH Ichikawa, K Shimizu, A Saito, et al.
Journal of Synchrotron Radiation|April 28, 2009
100 ps time-resolved solution scattering utilizing a wide-bandwidth X-ray beam from multilayer opticsK Ichiyanagi, T Sato, S Nozawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1983
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]M Shimoyama, H Yamada, T Kitahara, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotypeT Kagami, S Sahara, H Ichikawa, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazoleS Sahara, M Sugimoto, T Uotani, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2003
The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cellsN Yoshida, T Ishikawa, E Ichiishi, et al.
Pageof 47

Showing results (441-450 of 466) with videos related to

Sort By:
Pageof 47
Leukemia|October 7, 2015
A20 targets caspase-8 and FADD to protect HTLV-I-infected cellsY Saitoh, A Hamano, K Mochida, et al.
Artificial Organs|July 1, 1997
Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypassK Kagisaki, T Masai, K Kadoba, et al.
Oncogene|September 6, 2006
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinomaD G Jackson-Bernitsas, H Ichikawa, Y Takada, et al.
Genomics|April 1, 1996
A 1.6-Mb P1-based physical map of the Down syndrome region on chromosome 21M Ohira, H Ichikawa, E Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Long-distance restriction mapping of the proximal long arm of human chromosome 21 with Not I linking clonesH Ichikawa, K Shimizu, A Saito, et al.
Journal of Synchrotron Radiation|April 28, 2009
100 ps time-resolved solution scattering utilizing a wide-bandwidth X-ray beam from multilayer opticsK Ichiyanagi, T Sato, S Nozawa, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1983
[Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects]M Shimoyama, H Yamada, T Kitahara, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotypeT Kagami, S Sahara, H Ichikawa, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazoleS Sahara, M Sugimoto, T Uotani, et al.
Alimentary Pharmacology & Therapeutics|August 20, 2003
The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cellsN Yoshida, T Ishikawa, E Ichiishi, et al.
Pageof 47